Carbohydrate-modified carbonic anhydrase inhibitors: Advances and challenges.

Carbonic anhydrases (CAs) are a family of metalloenzymes that catalyze the reversible conversion of carbon dioxide into bicarbonate and proton, a key reaction involved in numerous physiological and pathological processes. Over the past few decades, C…

Preview only. Read the full abstract at the source